Giorgio Trinchieri, MD

Giorgio Trinchieri, MD, of the National Cancer Institute’s Center for Cancer Research joined CancerNetwork® to discuss enhancing the gut microbiome by way of fecal transplant for better immunotherapy responses.

A role for inflammation in cancer initiation and progression has been inferred for a long time, but it has only been in the last 10 to 15 years that the molecular mechanisms have been dissected such that targeting inflammatory pathways for cancer prevention and therapy has become a practical possibility.